In what could be a breakthrough in the treatment of neurological disease, a team led by physician-scientists at NewYork-Presbyterian Hospital/Weill Cornell Medical Center has completed the first-ever phase 1 clinical trial using gene therapy to battle Parkinson’s disease.
Obese and very obese patients have a lower risk of dying after they have been treated for heart attacks than do normal weight patients, according to research published in the European Heart Journal.
Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE), provides comment on the Women?s Health Initiative (WHI) Coronary Artery Calcium Study published in The New England Journal of Medicine (NEJM).
Researchers have found that the probability of the breast cancer gene mutation BRCA among women with a history of breast cancer is greater when the number of older, female relatives in the family is smaller, according to a study in the June 20 issue of JAMA.
Statement on the Ovarian Cancer Symptoms Consensus issued from the Ovarian & Gynecologic Cancer Coalition/Rhonda’s Club and In My Sister’s Care:
New research, revealing the true extent of abuse suffered by older people in the UK, was released today by Comic Relief, Chief Executive, Kevin Cahill and Health Minster, Ivan Lewis.
Although steroids are the most widely used treatment for sudden hearing loss, little scientific evidence supports their use or that of any other therapies for this condition, according to a systematic review and meta-analysis both published in the June issue of Archives of Otolaryngology-Head & Neck Surgery, one of the JAMA/Archives journals.
Scientists have found a novel signaling pathway in cells that is altered by genetic mutations recently identified in Parkinson disease development. These new findings show how the mutations affect cellular function and could provide a target for drug therapies to treat the disease.
In this review, Drs. Ian Thompson and Donna Ankerst examine the evidence in support of using prostate specific antigen testing, and then discuss how physicians should advise patients about the merits and drawbacks of the test.
University of Tennessee Graduate School of Medicine professor and researcher Alan Solomon, M.D., director of the Human Immunology and Cancer/Alzheimer?s Disease and Amyloid-Related Disorders Research Program, led a team that discovered a link between foie gras prepared from goose or duck liver and the type of amyloid found in rheumatoid arthritis or tuberculosis.